nach oben

Supportive Care in Cancer

Erschienen in:

19.12.2017 | Original Article

Applying pre-participation exercise screening to breast cancer survivors: a cross-sectional study

verfasst von: Lotachukwu T. Igwebuike, Xiaochen Zhang, Justin C. Brown, Kathryn H. Schmitz

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Clinical guidelines recommend that breast cancer (BrCa) survivors be prescribed exercise. However, clinicians often do not prescribe exercise citing the presence of multiple health issues found among cancer survivors. No study has examined the proportion of BrCa survivors that can be prescribed a community/home-based unsupervised exercise program safely and independently, without further medical investigations or supervision.

Methods

Participants included BrCa survivors who received treatment at a university healthcare system between 2009 and 2014. We applied previously identified published guidelines for health conditions that may impede BrCa survivors from completing a community/home-based exercise program. Logistic regression models were used to quantify the magnitude of the association between demographic and clinical characteristics and the ability to perform community/home-based exercise.

Results

Among 667 BrCa survivors, 65 to 75% was classified as able to complete community/home-based exercise as recommended by the clinical guidelines. Older age, black race, treatment with chemotherapy, and treatment with radiation were associated with the potential need for further medical evaluation prior to starting exercise.

Conclusions

A large proportion of BrCa survivors can be prescribed community/home-based exercise program safely and independently, without further medical investigations or supervision. Future research will be needed to determine how to identify the subset of BrCa survivors that may benefit from medical evaluation prior to starting exercise in a manner that does not interrupt clinical oncology workflow. Approximately 35% of BrCa survivors may benefit from medical evaluation prior to starting community/home-based exercise.

Nur mit Berechtigung zugänglich

Ligibel JA, Denlinger CS (2013) New NCCN guidelines® for survivorship care. J Natl Compr Cancer Netw 11(5S):640–644. https://doi.org/10.6004/jnccn.2013.0191 CrossRef

Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JKH, Lane K, Yasui Y, McKenzie DC (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404. https://doi.org/10.1200/JCO.2006.08.2024 CrossRefPubMed

Irwin, M. and A.C.o.S. Medicine, ACSM's guide to exercise and cancer survivorship. 2012: Human Kinetics

Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293(20):2479–2486. https://doi.org/10.1001/jama.293.20.2479 CrossRefPubMed

Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304(24):2699–2705. https://doi.org/10.1001/jama.2010.1837 CrossRefPubMed

Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, Lewis-Grant L, Bryan CJ, Williams-Smith CT, Greene QP (2009) Weight lifting in women with breast-cancer–related lymphedema. N Engl J Med 361(7):664–673. https://doi.org/10.1056/NEJMoa0810118 CrossRefPubMed

Denlinger CS, Engstrom PF (2011) Colorectal cancer survivorship: movement matters. Cancer Prev Res (Phila) 4(4):502–511. https://doi.org/10.1158/1940-6207.CAPR-11-0098 CrossRef

McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, Adams-Campbell LL, Woods N, Ockene J, Women’s Health Initiative Cohort Study (2003) Recreational physical activity and the risk of breast cancer in postmenopausal women: the women’s health initiative cohort study. JAMA 290(10):1331–1336. https://doi.org/10.1001/jama.290.10.1331 CrossRefPubMed

Moradi T, Adami HO, Ekbom A, Wedrén S, Terry P, Floderus B, Lichtenstein P (2002) Physical activity and risk for breast cancer a prospective cohort study among Swedish twins. Int J Cancer 100(1):76–81. https://doi.org/10.1002/ijc.10447 CrossRefPubMed

10.

Colditz G et al (2003) Physical activity and risk of breast cancer in premenopausal women. Br J Cancer 89(5):847–851. https://doi.org/10.1038/sj.bjc.6601175 CrossRefPubMedPubMedCentral

11.

Luoto R, Latikka P, Pukkala E, Hakulinen T, Vihko V (2000) The effect of physical activity on breast cancer risk: a cohort study of 30,548 women. Eur J Epidemiol 16(10):973–980. https://doi.org/10.1023/A:1010847311422 CrossRefPubMed

12.

Lee I-M, Rexrode KM, Cook NR, Hennekens CH, Buring JE (2001) Physical activity and breast cancer risk: the Women’s health study (United States). Cancer Causes Control 12(2):137–145. https://doi.org/10.1023/A:1008948125076 CrossRefPubMed

13.

Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL, American College of Sports Medicine (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409–1426. https://doi.org/10.1249/MSS.0b013e3181e0c112 CrossRefPubMed

14.

Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, Hamilton KK, Grant B, McCullough M, Byers T, Gansler T (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62(4):242–274. https://doi.org/10.3322/caac.21142 CrossRef

15.

Naci H, Ioannidis JPA (2013) Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ-British Med J 347(oct01 1):f5577. https://doi.org/10.1136/bmj.f5577 CrossRef

16.

Bluethmann SM, Mariotto AB, Rowland JH (2016) Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev 25(7):1029–1036. https://doi.org/10.1158/1055-9965.EPI-16-0133 CrossRef

17.

Sabatino SA, Coates RJ, Uhler RJ, Pollack LA, Alley LG, Zauderer LJ (2007) Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol 25(15):2100–2106. https://doi.org/10.1200/JCO.2006.06.6340 CrossRefPubMed

18.

Brown JC, Ko EM, Schmitz KH (2015) Development of a risk-screening tool for cancer survivors to participate in unsupervised moderate-to vigorous-intensity exercise: results from a survey study. PM&R 7(2):113–122. https://doi.org/10.1016/j.pmrj.2014.09.003 CrossRef

19.

Brown JC, Schmitz KH (2014) The prescription or proscription of exercise in colorectal cancer care. Med Sci Sports Exerc 46(12):2202–2209. https://doi.org/10.1249/MSS.0000000000000355 CrossRefPubMedPubMedCentral

20.

Zhang X, Haggerty AF, Brown JC, Giuntoli R II, Lin L, Simpkins F, Dean LT, Ko E, Morgan MA, Schmitz KH (2015) The prescription or proscription of exercise in endometrial cancer care. Gynecol Oncol 139(1):155–159. https://doi.org/10.1016/j.ygyno.2015.08.007 CrossRefPubMedPubMedCentral

21.

Bauml J et al (2017) Unsupervised exercise in survivors of human papillomavirus related head and neck cancer: how many can go it alone? J Cancer Surviv:1–7

22.

Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM (2005) Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 23(24):5814–5830. https://doi.org/10.1200/JCO.2005.01.230 CrossRefPubMedPubMedCentral

23.

Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474. https://doi.org/10.1245/s10434-010-0985-4 CrossRefPubMed

24.

Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383. https://doi.org/10.1016/0021-9681(87)90171-8 CrossRefPubMed

25.

Patnaik JL, Byers T, DiGuiseppi C, Denberg TD, Dabelea D (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst 103(14):1101–1111. https://doi.org/10.1093/jnci/djr188 CrossRefPubMedPubMedCentral

26.

McCaskill-Stevens W, Abrams JS (2011) Comorbidities in the aging breast cancer population: are current assessments leading to improved outcomes? J Natl Cancer Inst 103(14):1072–1073. https://doi.org/10.1093/jnci/djr239 CrossRefPubMedPubMedCentral

27.

Winters-Stone KM, Dobek J, Nail L, Bennett JA, Leo MC, Naik A, Schwartz A (2011) Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial. Breast Cancer Res Treat 127(2):447–456. https://doi.org/10.1007/s10549-011-1444-z CrossRefPubMedPubMedCentral

28.

Dobek J, Winters-Stone KM, Bennett JA, Nail L (2014) Musculoskeletal changes after 1 year of exercise in older breast cancer survivors. J Cancer Surviv 8(2):304–311. https://doi.org/10.1007/s11764-013-0313-7 CrossRefPubMed

29.

Rogers LQ, Courneya KS, Anton PM, Hopkins-Price P, Verhulst S, Vicari SK, Robbs RS, Mocharnuk R, McAuley E (2015) Effects of the BEAT cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial. Breast Cancer Res Treat 149(1):109–119. https://doi.org/10.1007/s10549-014-3216-z CrossRefPubMed

30.

Brown JC, Schmitz KH (2015) Weight lifting and physical function among survivors of breast cancer: a post hoc analysis of a randomized controlled trial. J Clin Oncol 33(19):2184–2189. https://doi.org/10.1200/JCO.2014.57.7395 CrossRefPubMedPubMedCentral

31.

Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, Ligibel J (2015) Randomized exercise trial of aromatase inhibitor–induced arthralgia in breast cancer survivors. J Clin Oncol 33(10):1104–1111. https://doi.org/10.1200/JCO.2014.57.1547 CrossRefPubMed

32.

Karvinen KH, Carr LJ, Stevinson C (2013) Resources for physical activity in cancer centers in the United States. Clin J Oncol Nurs 17(6):E71–E76. https://doi.org/10.1188/13.CJON.E71-E76 CrossRefPubMed

33.

Jain, R., and C.S. Denlinger (2017) Incorporating weight management into clinical care for cancer survivors: challenges, opportunities, and future directions. Obesity 25(S2)CrossRef

34.

Terranova CO, Lawler SP, Spathonis K, Eakin EG, Reeves MM (2017) Breast cancer survivors’ experience of making weight, dietary and physical activity changes during participation in a weight loss intervention. Support Care Cancer 25(5):1455–1463. https://doi.org/10.1007/s00520-016-3542-2 CrossRefPubMed

35.

Jones LW, Courneya KS (2002) Exercise counseling and programming preferences of cancer survivors. Cancer Pract 10(4):208–215. https://doi.org/10.1046/j.1523-5394.2002.104003.x CrossRefPubMed

36.

DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64(4):252–271. https://doi.org/10.3322/caac.21235 CrossRefPubMed

37.

Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30. https://doi.org/10.3322/caac.21332 CrossRefPubMed

38.

Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW (2008) The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67(2):124–132. https://doi.org/10.1016/j.critrevonc.2008.01.013 CrossRefPubMedPubMedCentral

Titel: Applying pre-participation exercise screening to breast cancer survivors: a cross-sectional study
verfasst von: Lotachukwu T. Igwebuike
Xiaochen Zhang
Justin C. Brown
Kathryn H. Schmitz
Publikationsdatum: 19.12.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 6/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-4020-1

Neu im Fachgebiet Onkologie

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

23.05.2024 Leitsymptome in der Hausarztpraxis Nachrichten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Applying pre-participation exercise screening to breast cancer survivors: a cross-sectional study

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

Das sind die führenden Symptome junger Darmkrebspatienten

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

Update Onkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Barriers for the implementation of guidelines in palliative care—results from a national survey of professionals

Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey

Influence of family on expected benefits of complementary and alternative medicine (CAM) in cancer patients

Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years

Sleep disturbance among Chinese breast cancer survivors living in the USA

Bismuth adjuvant and adverse effects of chemotherapy: issues with statistical analyses

Neu im Fachgebiet Onkologie

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

Das sind die führenden Symptome junger Darmkrebspatienten

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

Update Onkologie